Related Experiment Video

Updated: Aug 18, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potential

Candice Elam1, Luke Hesson, Michele D Vos

  • 1Department of Cell and Cancer Biology, National Cancer Institute, 9610 Medical Center Drive, Rockville, MD 20820, USA.

Cancer Research
|April 19, 2005
PubMed

Insights

Researchers discovered RRP22, a new Ras superfamily protein. This protein acts as a tumor suppressor by inhibiting cell growth and promoting cell death, offering potential in cancer therapy.

Area of Science:

  • Molecular biology
  • Cell biology
  • Oncology

Background:

  • Ras proteins are small GTPases with diverse cellular functions.
  • While some Ras proteins are oncogenic, others, like Rig and Noey2, function as tumor suppressors.
  • The Ras superfamily represents a critical area of cancer research.

Purpose of the Study:

  • To identify and characterize a novel member of the Ras superfamily.
  • To investigate the role of this new protein in cell growth and death.
  • To explore its potential as a tumor suppressor.

Main Methods:

  • Protein identification and characterization.
  • Analysis of post-translational modifications (farnesylation).
  • Cell growth and death assays (caspase-independent cell death).
  • Investigation of gene regulation (promoter methylation).
  • Functional studies in tumor cell lines (soft agar assay).
  • Subcellular localization studies (nucleolar localization).

Main Results:

  • A novel Ras superfamily member, RRP22, was identified and characterized.
  • RRP22 undergoes farnesylation, similar to Ras.
  • RRP22 inhibits cell growth and induces caspase-independent cell death.
  • RRP22 is frequently downregulated in human tumors due to promoter methylation.
  • Re-expression of RRP22 inhibits tumor cell growth in soft agar.
  • RRP22 localizes to the nucleolus in a GTP-dependent manner.

Conclusions:

  • RRP22 is a novel Ras superfamily protein with tumor-suppressive functions.
  • Its downregulation via promoter methylation in tumors suggests a role in tumorigenesis.
  • RRP22's nucleolar localization indicates a unique mechanism of action.
  • RRP22 represents a potential therapeutic target for cancer treatment.

More Related Videos

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein07:08

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.